Background: Immediate supply of red blood cell (RBC) concentrates is crucial in the initial treatment of exsanguinating patients in the emergency room. General shortage of RhD- RBCs has led to protocols in which patients with unknown blood groups are initially transfused with group O, RhD+ RBCs. Limited data are available regarding the safety of such an approach. Methods: Transfusion protocols for all multiple injured patients from the regional polytrauma database were retrospectively analyzed over a period of 5 years. Data on side effects were retrieved from the local safety update registry. Follow-up data were obtained from patients with identified RhD-incompatible transfusions. Results: In total, 823 patients were registered as multiple injured in the database. An immediate transfusion of 259 units (mean number of units 4, range 1-6) group O, RhD+ RBCs was initiated in 62 of them. 14 of these patients were RhD- and received 60 units of RhD-incompatible RBCs in the emergency room. In the later course RhD- patients received additional 185 incompatible transfusions (13; 1-31). The overall seroconversion rate was 50%. No adverse outcome due to incompatible transfusion was observed. Conclusions: Initial supply with group O, RhD+ RBCs in multiple injured patients appears to be safe. Significant numbers of RhD- units can be saved for use in other patients.

Keywords:
Non-cross-matched transfusions, Type O RhD+ supply, Emergency transfusion, Alloimmunization
1.
Deutsche Gesellschaft für Unfallchirurgie (federführend): S3 - Leitlinie Polytrauma/ Schwerverletzten-Behandlung. www.awmf.org/leitlinien/detail/ll/012-019.html (last accessed February 20, 2018)
2.
British Committee for Standards in Haematology, Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ: BCSH Guidelines on the management of massive blood loss Br J Haematol 2006;135:634-641.
3.
Murthi SB, Dutton RP, Edelman BB, Scalea TM, Hess JR: Transfusion medicine in trauma patients. Expert Rev Hematol 2008;1:99-109.
4.
Reid M, Lomas-Francis C, Olsson ML: The Blood Group Antigen Facts Book, 3rd ed. New York, Elsevier, 2012.
5.
Lefering R, Huber-Wagner S, Nienaber U. Maegele M, Bouillon B: Update of the trauma risk adjustment model of the TraumaRegister DGU™: the revised injury severity classification, version II. Crit Care 2014;18:476.
6.
Gervin AS, Fischer RP: Resuscitation of trauma patients with type-specific uncrossmatched blood. J Trauma 1984;24:327-331.
7.
Schwab CW, Shanye JP, Turner J: Immediate trauma resuscitation with type O uncrossmatched blood: a two-year prospective experience. J Trauma 1986;26:897-902.
8.
Lefebre J, McLellan BA, Coovadia AS: Seven years' experience with group O unmatched packed red blood cells in a regional trauma unit. Ann Emerg Med 1987;16:1344-1349.
9.
Dutton RP, Shih D, Edelman B, Hess J, Scalea TM: Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock. J Trauma 2005;59:1445-1449.
10.
Inaba K, Teixeira PGR, Shulman I, Nelson J, Lee J, Salim A, Brown C, Demetriades D, Rhee P: The impact of uncrossmatched blood transfusion on the need for massive transfusion and mortality: analysis of 5,166 uncross-matched units. J Trauma 2008;65:1222-1226.
11.
Miraflor E, Yeung L, Strumwasser A, Liu T, Victorino GP: Emergency uncrossmatched transfusion effect on blood type alloantibodies. J Trauma 2011;72:48-53.
12.
Mulay SB, Jaben EA, Johnson P, Badjie K, Stubbs J: Risks and adverse outcome associated with emergency-release red blood cell transfusion. Transfusion 2013;53:1416-1420.
13.
Schmidt PJ, Leparc GF, Samia CT: Use of Rh positive blood in emergency situations. Surg Gynecol Obstet 1988;167:229-233.
14.
Meyer E, Uhl L: A case for stocking O D+ red blood cells in emergency room trauma bay. Transfusion 2015;55:791-795.
15.
Selleng K, Jenichen G, Denker K, Selleng S, Müllejans B, Greinacher A: Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective single-centre, observational study. Lancet Haematol 2017;4:e218-e224.
16.
Frohn C, Dümbgen L, Brand J-M, Görg S, Luhm J, Kirchner H: Probability of anti-D development in D-patients receiving D+ RBCs. Transfusion 2003;43:893-898.
17.
Yazer MH, Triulzi DJ: Detection of anti-D in D-recipients transfused with D+ red blood cells. Transfusion 2007;47:2197-2201.
18.
Gonzalez-Porras JG, Graciani IF, Perez-Simon JA, Martin-Sanchez J, Encinas C, Conde MP, Nieto MJ, Corral M: Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008;17:1318-1324.
19.
Gunson HH, Stratton F, Cooper DG, Rawlinson VI: Primary immunization of Rh-negative volunteers. Br Med J 1970;1:593-595.
20.
Urbaniak SJ, Robertson AE: A successful program of immunizing Rh-negative male volunteers for anti-D production using frozen/thawed blood. Transfusion 1981;21:64-69.
21.
Beckman N, Yazer M, Land K, Chesneau S, Cauldfield J: Blood banks meet the paradox of Gabriel´s Horn: what are the options to maintain supply as demand decreases? Transfus Med 2016;26:170-176.
22.
Newman BH, Shafer AW, Saeed SM: Patterns of use of group O, Rh-negative red cells in a large metropolitan area and an action plan to control utilization. Transfusion 1996;36:209-212.
23.
NHS, The Chief Medical Officer's National Blood Transfusion Committee: The appropriate use of group O RhD negative red cells. www.transfusionguidelines.org/document-library/documents/nbtc-recommendations-on-the-appropriate-use-of-group-0-rhd-negative-red-cells-revised-april-2009/download-file/nbtc_bbt_o_neg_red_cells_recs_09_04.pdf+&cd=1&hl=de&ct=clnk&gl=de (last accessed February 22, 2018).
24.
Schäfer N, Driessen A, Fröhlich M, Stürmer EK, Maegele M; TACTIC partners:. Diversity in clinical management and protocols for the treatment of major bleeding trauma patients across European level I Trauma Centres. Scand J Trauma Resusc Emerg Med 2015;23:74.
25.
German Guidelines for Production of Blood and Blood Derived Factors and for Hemotherapy. Cologne, Deutscher Ärzteverlag, 2017, chapter 4.10.5.
26.
Ramsey G, Hahn LF, Cornell FW, Boczkowski DJ, Staschak S, Clark R, Hardesty RL, Griffith BP, Starzl TW: Low rate of rhesus immunization from Rh-incompatible blood transfusions during liver an heart transplant surgery. Transplantation 1989;47:993-995.
27.
Schonewille H, Haak HL, Zijl AM: Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999;39:763-771.
28.
Asfour M, Narvios A, Lichtiger B: Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. Med Gen Med 2004;13:22.
29.
Casanueva M, Valdes MD, Ribera MC: Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 2008;34:570-572.
© 2018 S. Karger GmbH, Freiburg
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.